EGFR exon 20 insertion mutation in Japanese lung cancer
Authors:
- Hidefumi SasakiHSHidefumi Sasaki
- Katsuhiko EndoKEKatsuhiko Endo
- Minoru TakadaMTMinoru Takada
- Masaaki KawaharaMKMasaaki Kawahara
- Naoto KitaharaNKNaoto Kitahara
- Hisaichi TanakaHTHisaichi Tanaka
- Meinoshin OkumuraMOMeinoshin Okumura
- Akihide MatsumuraAMAkihide Matsumura
- Keiji IuchiKIKeiji Iuchi
- Tomoya KawaguchiTKTomoya Kawaguchi
- Osamu KawanoOKOsamu Kawano
- Haruhiro YukiueHYHaruhiro Yukiue
- 1 December 2007
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 58 (3) , 324-328
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencingNature Medicine, 2006
- EGFR and erbB2 mutation status in Japanese lung cancer patientsInternational Journal of Cancer, 2005
- Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR MutantsPLOS Medicine, 2005
- EGFR Mutation Status in Japanese Lung Cancer Patients: Genotyping Analysis Using LightCyclerClinical Cancer Research, 2005
- Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung CancersJNCI: Journal of the National Cancer Institute, 2005
- Mutations of the Epidermal Growth Factor Receptor Gene in Lung CancerCancer Research, 2004
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- EGFR and cancer prognosisEuropean Journal of Cancer, 2001